Human Blood Samples for Diagnostic Development in USA
iBioSpecimen supports diagnostic development programs in the USA by providing ethically sourced human blood samples suitable for early-stage assay design, biomarker discovery, feasibility testing, and diagnostic workflow optimization. Human blood is one of the most important specimen types for developing new diagnostic platforms because it can contain clinically relevant cells, plasma proteins, serum markers, circulating nucleic acids, immune signatures, and disease-associated biomarkers. For companies working on molecular diagnostics, immunoassays, hematology platforms, companion diagnostics, infectious disease testing, oncology biomarkers, autoimmune panels, or metabolic testing, access to well-characterized blood samples can help accelerate assay development and improve test performance before larger validation studies begin.
At iBioSpecimen, blood sample procurement can be supported according to project-specific needs, including whole blood, plasma, serum, buffy coat, PBMCs, and disease-specific or healthy donor cohorts where available. Samples may be collected with relevant donor information, collection tube type, processing details, storage conditions, and clinical annotations, subject to ethical approvals and consent requirements. Our goal is to help diagnostic companies, CROs, biotech firms, and research laboratories in the USA access reliable human biospecimens for diagnostic innovation. Whether the requirement is for small pilot lots or larger customized collections, iBioSpecimen can assist with feasibility assessment, sourcing strategy, documentation, and compliant shipment coordination.
Blood Samples for IVD and Diagnostic Assay Development in USA
For in vitro diagnostic developers, high-quality human blood samples are essential for building reliable assays that can perform accurately in real-world clinical settings. Blood samples are commonly used in the development of IVD tests for oncology, infectious diseases, cardiovascular conditions, autoimmune disorders, diabetes, genetic testing, liquid biopsy, immunology, and biomarker-based screening. During assay development, researchers may require different blood components such as serum, plasma, whole blood, buffy coat, or cellular fractions to evaluate assay sensitivity, specificity, reproducibility, matrix effects, and biomarker stability. Having a
Blood Samples for IVD and Diagnostic Assay Development in USA
iBioSpecimen supports diagnostic development programs in the USA by providing ethically sourced human blood samples suitable for early-stage assay design, biomarker discovery, feasibility testing, and diagnostic workflow optimization. Human blood is one of the most important specimen types for developing new diagnostic platforms because it can contain clinically relevant cells, plasma proteins, serum markers, circulating nucleic acids, immune signatures, and disease-associated biomarkers. For companies working on molecular diagnostics, immunoassays, hematology platforms, companion diagnostics, infectious disease testing, oncology biomarkers, autoimmune panels, or metabolic testing, access to well-characterized blood samples can help accelerate assay development and improve test performance before larger validation studies begin.
At iBioSpecimen, blood sample procurement can be supported according to project-specific needs, including whole blood, plasma, serum, buffy coat, PBMCs, and disease-specific or healthy donor cohorts where available. Samples may be collected with relevant donor information, collection tube type, processing details, storage conditions, and clinical annotations, subject to ethical approvals and consent requirements. Our goal is to help diagnostic companies, CROs, biotech firms, and research laboratories in the USA access reliable human biospecimens for diagnostic innovation. Whether the requirement is for small pilot lots or larger customized collections, iBioSpecimen can assist with feasibility assessment, sourcing strategy, documentation, and compliant shipment coordination.
Blood Samples for IVD and Diagnostic Assay Development in USA
iBioSpecimen supports diagnostic development programs in the USA by providing ethically sourced human blood samples suitable for early-stage assay design, biomarker discovery, feasibility testing, and diagnostic workflow optimization. Human blood is one of the most important specimen types for developing new diagnostic platforms because it can contain clinically relevant cells, plasma proteins, serum markers, circulating nucleic acids, immune signatures, and disease-associated biomarkers. For companies working on molecular diagnostics, immunoassays, hematology platforms, companion diagnostics, infectious disease testing, oncology biomarkers, autoimmune panels, or metabolic testing, access to well-characterized blood samples can help accelerate assay development and improve test performance before larger validation studies begin.
At iBioSpecimen, blood sample procurement can be supported according to project-specific needs, including whole blood, plasma, serum, buffy coat, PBMCs, and disease-specific or healthy donor cohorts where available. Samples may be collected with relevant donor information, collection tube type, processing details, storage conditions, and clinical annotations, subject to ethical approvals and consent requirements. Our goal is to help diagnostic companies, CROs, biotech firms, and research laboratories in the USA access reliable human biospecimens for diagnostic innovation. Whether the requirement is for small pilot lots or larger customized collections, iBioSpecimen can assist with feasibility assessment, sourcing strategy, documentation, and compliant shipment coordination.